Friday, August 28, 2015| Latest E-book
You are here:
Drugmakers
#

Drugmakers

Articles

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said. #Sun Pharma #Ranbaxy #Dilip Shanghvi #drugmaker
US drugmaker Merck grants free license for pediatric HIV drug

Feb 24, 2015

US drugmaker Merck grants free license for pediatric HIV drug

Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus. #US #NewsTracker #HIV #Drugs #drugmaker #Merck #pediatric
India battles HIV/AIDS drug shortage as some firms halt supply

Sep 04, 2014

India battles HIV/AIDS drug shortage as some firms halt supply

India is facing a shortage of HIV/AIDS drugs provided under government's free medicine programme after drugmakers halted supplies due to delayed payment #NewsTracker #HIV #AIDS #HIV drugs #Indian drugmakers #NACO #shortage of medicine
Uh oh.. is Ranbaxy in more trouble?

Jan 13, 2014

Uh oh.. is Ranbaxy in more trouble?

The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to nearly a one-month low. #United States #Ranbaxy #Daiichi Sankyo #US FDA #drugmaker #Toansa
Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

Nov 28, 2013

Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Aug 12, 2013

US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. #United States #NewsTracker #US FDA #drugmaker #Indian drugmakers
Ranbaxy $500 mn fine Why single out India and Ranbaxy?

Jun 05, 2013

Ranbaxy $500 mn fine Why single out India and Ranbaxy?

Ranbaxy may be facing a potential ban on its generic drugs in United States but however Ranbaxy is not the only company that has faced such a crisis. #WhyNow #Ranbaxy Laboratories #US FDA #generic drugmakers
Ranbaxy's $500 mn settlement: All you need to know

May 14, 2013

Ranbaxy's $500 mn settlement: All you need to know

Ranbaxy will pay $500 mn to resolve fraud allegations that the company sold adulterated drugs and lied about it to US regulators. #US #CompanyWatch #Ranbaxy #Pharma #generic drugmakers
US trade office reviewing SC ruling against Novartis

Apr 03, 2013

US trade office reviewing SC ruling against Novartis

The United States is considering its response to the Supreme Court ruling against Novartis, which US drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in India. #WhatNext #Novartis #big pharma #Drugmakers #US trade body
Novartis patent blow: Why Big Pharma can't quit India

Apr 03, 2013

Novartis patent blow: Why Big Pharma can't quit India

Much of the new business will still come from cheap generics made by local companies, but Western firms are also seeking to put their brands on unpatented medicines, prompting the likes of Abbott Laboratories and Daiichi Sankyo to buy up Indian companies. #TheLongView #Glenmark Generics Limited #Novartis #big pharma #Drugmakers